sarepta

1 page

Newsletters Does the FDA need to slow its drug approval roll?
BYSy Mukherjee
January 22, 2020
Health Controversial Biotech Sarepta Keeps Up Unlikely Win Streak With $1.15 Billion Roche Deal
BYSy Mukherjee
December 23, 2019
Newsletters FDA Approves Sarepta Duchenne Drug in Stunning Reversal
BYSy Mukherjee
December 14, 2019
Health Why Sarepta Stock Skyrocketed 40% Today
BYSy Mukherjee
June 19, 2018
Health This Controversial Biotech May Yet Defy Its Skeptics
BYSy Mukherjee
September 6, 2017
Health Drug Giant Sanofi May Be Getting Ready to Buy Up This Rare Disease Company
BYSy Mukherjee
April 28, 2017

Health Gilead Just Paid $125 Million to Nab a Big Market Advantage
BYSy Mukherjee
February 21, 2017
Health Drug Company Hits Pause on Launching an $89,000 Muscular Dystrophy Drug After Backlash
BYSy Mukherjee
February 13, 2017
Health This Pharma Company Is Selling a Decades-old Drug to Treat Muscular Dystrophy for $89,000
BYSy Mukherjee
February 10, 2017
Health Insurers are Rebelling Against the FDA’s Most Controversial 2016 Drug Approval
BYSy Mukherjee
December 14, 2016
Health Why This Controversial Biotech Stock Just Soared More Than 88%
BYSy Mukherjee
November 12, 2016
Health The FDA’s Most Controversial Drug Approval of the Year Just Hit a Huge Snag
BYSy Mukherjee
October 7, 2016
Health The FDA Just Made Its Most Controversial Drug Approval of the Year
BYSy Mukherjee
September 19, 2016
Health This Drug Company’s Shares Are Up 20% Today
BYReuters
May 25, 2016
Health This Rare Children’s Disease Drug Is Pitting Patients Against the FDA
BYSy Mukherjee
April 26, 2016

Most Popular

1 - 15 of 15 results